| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JXSL1700038 | 注射用替伊莫单抗 | ibritumomab tiuxetan | Lyophilized | Biological Products | Import Drug Application | 2017-07-11 | 英创远达（北京）生物医药科技有限公司 | CASI(Beijing)Pharmaceuticals Technology Co Ltd | In Review | 2017-07-08 | view |